SJRWF - Merger Arbitrage Mondays: Pfizer Acquires Arena Pharmaceuticals At A 100% Premium
- The acquisition of Arena Pharmaceuticals by Pfizer for $4.69 billion.
- The announcement to acquire Arena comes less than a month after Pfizer closed another $2.2 billion deal.
- Bottomline Technologies (EPAY), a potential deal in the works, signed a merger agreement with Thoma Bravo.
For further details see:
Merger Arbitrage Mondays: Pfizer Acquires Arena Pharmaceuticals At A 100% Premium